Valuation: Vineet Laboratories Limited

Market Cap 558M 5.88M 5.25M 4.9M 4.44M 8.35M 8.42M 58.65M 22.96M 290M 22.08M 21.6M 931M P/E 2024
43.6x
P/E 2025 -1.42x
Enterprise Value 956M 10.07M 8.99M 8.38M 7.6M 14.3M 14.41M 100M 39.31M 497M 37.81M 36.98M 1.59B EV / Sales 2024
587,502x
EV / Sales 2025 890,202x
Free-Float
65.45%
Yield 2024 *
-
Yield 2025 -
08-25 Vineet Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
07-21 Vineet Laboratories Limited Announces Cessation of Gaddam Venkata Ramana to Hold the Office of Managing Director, Effective July 21, 2026 CI
05-29 Vineet Laboratories Limited Announces Resignation of Ramesh Kumar Bandari from Company Secretary and Compliance Officer and Ceases to Be Key Managerial Personnel, Effective May 29, 2026 CI
02-14 Vineet Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
02-07 Vineet Laboratories Limited Approves Appointment of Jasmin Kunal Tailor as Independent Director CI
12-17 Vineet Laboratories says rights issue price set at 30 rupees per share RE
11-27 Vineet Laboratories Gets Board Nod to Raise Up to INR300 Million via Rights Issue MT
11-27 Vineet Laboratories to raise funds up to 300 million rupees via rights issue RE
11-24 Vineet Laboratories to consider rights issue RE
11-08 Vineet Laboratories Limited Announces Resignation of Hari Priya Yerukalapudi as Independent Director, Effective November 08, 2025 CI
16/09/25 Vineet Laboratories Limited Approves the Appointment of Premananda Reddy Vennapusa as Non-Executive Director, Effective from September 15, 2025 CI
22/07/25 Vineet Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
12/05/25 Vineet Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
1 day+1.74%
1 week+5.29%
Current month+3.85%
1 month+8.37%
3 months+11.44%
6 months+18.78%
Current year+4.92%
1 week 34.61
Extreme 34.61
39.47
1 month 34.1
Extreme 34.1
39.47
Current year 27.96
Extreme 27.96
43.5
1 year 27.96
Extreme 27.96
49.99
3 years 26.51
Extreme 26.51
88.9
5 years 26.51
Extreme 26.51
92
10 years 26.51
Extreme 26.51
124
Manager TitleAgeSince
Director of Finance/CFO 76 31/12/2020
Human Resources Officer - -
Comptroller/Controller/Auditor - -
Director TitleAgeSince
Director/Board Member 57 09/11/2016
Director/Board Member 76 09/11/2016
Chairman 73 15/11/2020
Change 5-day change 1-year change 3-year change Capi.($)
+1.74%+5.29%-5.76%-25.36% 7.67M
-1.36%+0.78%+42.36%+91.48% 1,040B
-5.73%-2.42%+30.23%+58.50% 599B
-2.40%+2.88%+19.13%+85.43% 485B
-2.39%+0.03%+65.67%+36.51% 350B
+1.39%+1.44%+27.60%+44.83% 345B
+1.31%+0.92%+16.42%+38.90% 272B
+0.77%-1.67%-5.98%+9.16% 244B
-1.13%+2.54%+41.19%+45.32% 223B
-1.67%+2.56%+25.13%+90.50% 183B
Average +0.90%+2.53%+25.60%+47.53% 374.28B
Weighted average by Cap. +0.82%+2.31%+32.27%+63.96%

Financials

2024 2025
Net sales 1.51K 15.9 14.21 13.24 12.01 22.59 22.77 158.63 62.1 785.12 59.73 58.42 2.52K 769.53 8.11 7.24 6.75 6.12 11.52 11.61 80.86 31.66 400.21 30.45 29.78 1.28K
Net income 10.27M 108K 96.66K 90.09K 81.68K 154K 155K 1.08M 423K 5.34M 406K 397K 17.14M -202M -2.13M -1.9M -1.77M -1.61M -3.02M -3.05M -21.22M -8.31M -105M -7.99M -7.81M -337M
Net Debt 441M 4.64M 4.15M 3.87M 3.5M 6.6M 6.65M 46.31M 18.13M 229M 17.44M 17.05M 735M 397M 4.19M 3.74M 3.49M 3.16M 5.95M 5.99M 41.76M 16.35M 207M 15.72M 15.38M 663M
Projected Income Statement - Annual - Vineet Laboratories Limited
Logo Vineet Laboratories Limited
Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.
Employees
57
Date Price Change Volume
14/10/26 ₹38.59 +1.74% 103,266
13/10/26 ₹37.93 +1.69% 119,171
12/10/26 ₹37.30 -0.40% 86,868
09/10/26 ₹37.45 +2.60% 54,462
08/10/26 ₹36.50 -0.41% 66,511
  1. Stock Market
  2. Stocks
  3. VINEETLAB Stock